IONIS Pharma
Stock
Stock
Ticker: IONS
IONS
Price
Price
CHART BY
Frequently asked questions
What is IONIS Pharma's market capitalization?
The market capitalization of IONIS Pharma is $7.54B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for IONIS Pharma?
IONIS Pharma's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$3.473. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for IONIS Pharma's stock?
Currently, 28 analysts cover IONIS Pharma's stock, with a consensus target price of $84.14. Analyst ratings provide insights into the stock's expected performance.
What is IONIS Pharma's revenue over the trailing twelve months?
Over the trailing twelve months, IONIS Pharma reported a revenue of $873.76M.
What is the EBITDA for IONIS Pharma?
IONIS Pharma's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$567.97M. EBITDA measures the company's overall financial performance.
What is the free cash flow of IONIS Pharma?
IONIS Pharma has a free cash flow of -$560.84M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does IONIS Pharma have, and what sector and industry does it belong to?
IONIS Pharma employs approximately 1,402 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of IONIS Pharma's shares?
The free float of IONIS Pharma is 162.92M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $7.54B
- EPS (TTM)
- -$3.473
- Free Float
- 162.92M
- Revenue (TTM)
- $873.76M
- EBITDA (TTM)
- -$567.97M
- Free Cashflow (TTM)
- -$560.84M
Pricing
- 1D span
- $43.50$45.37
- 52W span
- $42.22$86.74
Analyst Ratings
The price target is $84.14 and the stock is covered by 28 analysts.
Buy
24
Hold
4
Sell
0
Information
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
- Employees
- 1,402
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- IONS
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet